Internal Medicine, Addiction Medicine · Bristol, VA
NPI
1215224902
Since 2011
Specialty
Internal Medicine, Addiction Medicine
Code 207RA0401X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1662 Bonham Rd
Bristol, VA, 24201
Phone (276) 644-9899
Groups this clinician bills Medicare through
Medicare paid, 2024
$67K
575 services
Medicare patients, 2024
62
Average age 55
Drug cost, 2024
$604K
6,781 prescriptions
Company payments, 2025
$1,131
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Joshua A Morris was code 99214 (office e&m - established), 92 times for 30 patients. In total Joshua A Morris billed 575 services in 20 codes, and Medicare paid $67K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-06-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 92 | 30 | $86.86 | $7,991 |
| G2087 Office-based treatment for opioid use disorder, including care coordination, individual therapy and group therapy and counseling; at least 60 minutes in a subsequent calendar month | Office | 80 | 27 | $295.62 | $24K |
| G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 79 | 23 | $241.19 | $19K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 71 | 14 | $40.72 | $2,891 |
| 80307 Drug Tests | Office | 69 | 24 | $60.90 | $4,202 |
| 99213 Office E&M - Established | Office | 61 | 24 | $61.35 | $3,742 |
| 99406 Behavioral Health Services | Office | 30 | 15 | $13.00 | $390 |
| 36415 Venipuncture Blood Collection | Office | 16 | 13 | $8.42 | $135 |
By year: 2022 $96K for 839 services; 2023 $93K for 763 services; 2024 $67K for 575 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 79 | 23 | $241.19 | $19K |
| 80307 Drug Tests | 69 | 24 | $60.90 | $4,202 |
| 36415 Venipuncture Blood Collection | 16 | 13 | $8.42 | $135 |
Medicare prescription drug claims, 2024
In 2024, the drug Joshua A Morris prescribed most often to Medicare patients was Buprenorphine-Naloxone (Buprenorphine Hcl/Naloxone Hcl), with 831 prescriptions and refills. In total Joshua A Morris wrote 6,781 Medicare prescriptions that cost $604K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Buprenorphine-Naloxone Buprenorphine Hcl/Naloxone Hcl | 831 | 831 | 142 | $44K |
| Clonazepam Generic | 435 | 435 | 64 | $2,180 |
| Gabapentin Generic | 390 | 392 | 70 | $4,390 |
| Duloxetine Hcl Generic | 206 | 259 | 41 | $2,388 |
| Rosuvastatin Calcium Generic | 198 | 296 | 44 | $1,132 |
| Lisinopril Generic | 176 | 252 | 36 | $664 |
| Pantoprazole Sodium Generic | 142 | 200 | 31 | $646 |
| Potassium Chloride Generic | 134 | 183 | 25 | $929 |
| Amitriptyline Hcl Generic | 127 | 137 | 23 | $1,467 |
| Pregabalin Generic | 123 | 123 | 28 | $2,256 |
| Atorvastatin Calcium Generic | 121 | 168 | 27 | $496 |
| Omeprazole Generic | 119 | 141 | 18 | $1,247 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 118 | 130 | 31 | $2,540 |
| Buprenorphine Hcl Generic | 117 | 117 | 16 | $2,879 |
| Furosemide Generic | 109 | 138 | 23 | $351 |
Brand drugs: 717 claims; generic drugs: 6,046 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Joshua A Morris $1,131 ($1,131 in general payments such as food, travel and fees) from 11 companies. The largest payer was Abbvie Inc. with $315.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 37 | $315 |
| Vanda Pharmaceuticals Inc. VNDA | 11 | $181 |
| Indivior Inc. INDV | 5 | $144 |
| Braeburn Inc. | 18 | $141 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 3 | $83.04 |
| Novo Nordisk Inc NVO | 4 | $70.86 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 3 | $61.26 |
| Gilead Sciences, Inc. GILD | 2 | $44.82 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $43.89 |
| Inspire Medical Systems, Inc. INSP | 1 | $30.59 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.